SARcode Biosciences sarcode.com


Public lists: Eye Health (691)

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-cell mediated, ophthalmic and dermatologic diseases including dry eye, diabetic retinopathy, eczema and psoriasis. In March 2013, SARcode Biosciences was acquired by Shire. The valuation of SARcode Biosciences was $160 million.. Other terms of the deal were not released.

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-cell mediated, ophthalmic and dermatologic diseases...Show all

Company (Acquired)

Phone: 650-416-7560

Fax:

1000 Marina Blvd
Suite 250
Brisbane, 94005
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SARcode Biosciences $73.2M Mar 25, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SARcode Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alta PartnersVenture CapitalSan Francisco, California, United StatesSeries B, Series A
ClarusVenture CapitalCambridge, Massachusetts, United StatesSeries B, Series A
Rho VenturesVenture CapitalNew York, New York, United StatesSeries B
Qualifying Therapeutic Discovery ProjectGovernmentWashington, DC, United StatesGrant
Sofinnova VenturesVenture CapitalMenlo Park, California, United StatesSeries B
See all 5 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Crystalline pharmaceutical and methods of preparation and use thereof May 03, 2016 Feb 13, 2018 Patent
Continuous flow carboxylation reaction Sep 25, 2015 Aug 08, 2017 Patent
Lfa-1 inhibitor and methods of preparation and polymorph thereof Jun 23, 2015 Jul 18, 2017 Patent
Compositions and methods for treatment May 12, 2014 Jun 09, 2015 Patent
Compositions and methods for treatment May 12, 2014 Jun 02, 2015 Patent
See all 42 patents